Bryan Steadman Email

Chief Technical Officer and Head R&D . VitriVax

Current Roles

Employees:
34
Revenue:
$5.3M
About
VitriVax is commercializing a vaccine formulation platform enabling thermostability, and combined doses with timed release, for virtually any injectable vaccine. Our proprietary technology, created at the University of Colorado in Boulder with the support of over $5M from NIH, NSF and the State of Colorado, and most recently, $2.2M from the Bill and Melinda Gates Foundation, makes human and animal vaccines more effective, more affordable, and more accessible globally.
VitriVax Address
5435 Airport Boulevard
Boulder, CO
United States
VitriVax Email

Past Companies

VitriVaxChief Technical Officer and Head R&D
CMC Logic LLCFounder and Biopharmaceutical CMC Advisor
Universal CellsChief Technology Officer

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.